Source: Virtual Congress 2021 – Advances in asthma treatment



Rating:

Share or cite this content

Citations should be made in the following way:
A. Markus (Rotterdam, Netherlands), P. Rijnbeek (Rotterdam, Netherlands), J. Kors (Rotterdam, Netherlands), G. Brusselle (Ghent, Belgium), E. Burn (Oxford, United Kingdom), D. Prieto-Alhambra (Oxford, United Kingdom), K. Verhamme (Rotterdam, Netherlands). Real-world treatment patterns of newly diagnosed patients with asthma and/or COPD. 3520

Member's Comments

No comment yet.

Related content which might interest you: Characteristics and treatment patterns of newly diagnosed COPD patients in Canada Source: International Congress 2019 – COPD clinical studies: bronchodilators, corticosteroids and more Year: 2019 Comparison of inhaler device preference of the physicians in the treatment of newly diagnosed adult asthma and COPD patients Source: International Congress 2019 – Inhalers: adherence and preference Year: 2019 Patterns of co-morbidities in newly diagnosed asthma Source: Annual Congress 2010 - From diagnosis to disease management in primary care Year: 2010 The clinical impact of long-acting bronchodilators in newly diagnosed COPD patients Source: Annual Congress 2013 –Asthma and COPD drugs: efficacy, safety and pharmacoeconomics Year: 2013 Patients at risk for COPD compared to patients diagnosed with COPD Source: Annual Congress 2009 - Epidemiology of COPD Year: 2009 COPD patients with asthma, characteristics and risk of exacerbations Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019 Severe outcomes of COVID-19 among patients with COPD and asthma Source: ERJ Open Res, 7 (1) 00594-2020; 10.1183/23120541.00594-2020 Year: 2021 Predictors of inhaled corticosteroid therapy in COPD alone compared to COPD with concomitant asthma managed in primary care Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019 Markers of T2-inflammation in patients with severe asthma and concomitant COPD Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease Year: 2020 The impact of using different symptom-based exacerbation definitions in COPD patients Source: Annual Congress 2010 - Exacerbations and COPD and rehabilitation Year: 2010 Differences between newly and previously diagnosed COPD patients in a spirometry program Source: Annual Congress 2009 - Diagnostic strategies in primary respiratory care Year: 2009 Real-world prescribing patterns among newly diagnosed COPD patients receiving ICS: An analysis of UK patient dataset Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments Year: 2014 The prevalence and clinical characteristics of asthma–COPD overlap syndrome (ACOS) in patients with COPD Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer Year: 2017 Sexuality in patients with asthma and/or COPD Source: Eur Respir J 2003; 22: Suppl. 45, 54s Year: 2003 Assessment of a disease management program for patients with asthma or COPD Source: Eur Respir J 2005; 26: Suppl. 49, 19s Year: 2005 Effect of exacerbation history and ICS use on outcomes in COPD patients from the TIOSPIR™ trial Source: International Congress 2015 – New data on established treatments for COPD Year: 2015 Life-sustaining treatment preferences of patients with severe COPD Source: Annual Congress 2010 - Pulmonary rehabilitation and chronic care: new developments in interventions, assessment and care Year: 2010 Antecedent hospitalization history of patients newly diagnosed with COPD Source: Virtual Congress 2020 – New tools for diagnosis of obstructive diseases Year: 2020 Real-world treatment patterns of benralizumab therapy for patients with severe asthma Source: Virtual Congress 2020 – Diagnosis and management of asthma Year: 2020 Real-world medication use patterns in stable COPD patients from Romania Source: International Congress 2019 – COPD treatment: cohorts and real-world studies Year: 2019